In a pregnant patient with suspected intrauterine growth restriction, how do symmetric (proportionate) and asymmetric (head‑sparing) IUGR differ in timing, etiology, ultrasound and Doppler findings, and clinical management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symmetric vs. Asymmetric IUGR: Key Distinctions

Symmetric IUGR occurs predominantly in early gestation (typically <28-32 weeks) due to chromosomal anomalies, congenital syndromes, and viral infections, while asymmetric IUGR with head-sparing develops later (≥32 weeks) from placental insufficiency related to maternal hypertensive disease. 1

Timing and Gestational Age Thresholds

  • Symmetric IUGR is more common earlier in gestation, with proposed thresholds at 28,32, or 34 weeks representing different pathologies and etiologies 1
  • Asymmetric IUGR with "head-sparing" characteristically appears later in gestation when placental insufficiency predominates 1, 2
  • The distinction matters because early-onset disease (<32 weeks) warrants genetic testing including chromosomal microarray analysis, which provides 4-10% incremental diagnostic yield over standard karyotyping 2

Etiology and Pathophysiology

Symmetric IUGR (Proportionate Growth Restriction)

  • Chromosomal anomalies, genetic syndromes, and viral infections are the primary causes in early gestation 1
  • Chromosomal disorders and congenital malformations together account for approximately 20% of all FGR cases 2
  • All fetal parameters (head circumference, abdominal circumference, femur length) are proportionately reduced 3
  • The insult typically occurs early in pregnancy, affecting the fundamental growth potential of all fetal structures 3

Asymmetric IUGR (Head-Sparing Growth Restriction)

  • Placental insufficiency is the dominant cause, accounting for 25-30% of all FGR cases 2
  • Maternal hypertensive disorders and vascular disease are key associations with late-onset asymmetric FGR 2
  • The fetus redistributes blood flow preferentially to protect the brain at the expense of abdominal/somatic growth 2
  • Abdominal circumference is disproportionately reduced while head circumference and length are relatively preserved 3

Important caveat: Recent evidence challenges the traditional teaching that asymmetric IUGR is confined to the third trimester. A 2011 study found that 58% of severe, early-onset IUGR cases (<33 weeks) due to placental insufficiency demonstrated an asymmetric phenotype with elevated head circumference/abdominal circumference ratio ≥95th percentile—more than 10-fold greater than expected 4. This suggests asymmetric patterns can occur earlier than previously believed when placental disease is severe.

Ultrasound and Doppler Findings

Biometric Assessment

  • Symmetric IUGR: All biometric parameters (biparietal diameter, head circumference, abdominal circumference, femur length) fall proportionately below the 10th percentile 1
  • Asymmetric IUGR: Head circumference/abdominal circumference ratio ≥95th percentile indicates preferential head-sparing 4
  • Estimated fetal weight (EFW) below the 10th percentile defines FGR; below the 3rd percentile defines severe FGR with stillbirth rates up to 2.5% 5, 6

Doppler Velocimetry Patterns

  • Umbilical artery Doppler is essential for differentiating pathological growth restriction from constitutional smallness 6, 7
  • Elevated pulsatility index, resistance index, or absent/reversed end-diastolic velocity confirms placental insufficiency 5, 6
  • Middle cerebral artery Doppler and cerebroplacental ratio demonstrate brain-sparing redistribution in asymmetric IUGR 1, 5
  • Ductus venosus Doppler with reversed A-wave flow is abnormal throughout gestation and indicates severe fetal compromise 1
  • Uterine artery Doppler combined with umbilical artery Doppler offers better prediction of adverse perinatal outcomes than either measure alone 1

Additional Sonographic Markers

  • Oligohydramnios suggests chronic placental dysfunction 5
  • Reduced growth velocity (AC change <5mm over 14 days or >30% reduction in growth velocity) indicates progressive pathology 5, 6
  • Approximately 10% of fetuses with FGR have congenital anomalies, and 20-60% of fetuses with congenital anomalies are SGA, necessitating detailed structural surveys 1, 2

Clinical Management Approach

Initial Diagnostic Workup

For Early-Onset IUGR (<32 weeks):

  • Perform detailed fetal structural survey to identify the 10% with congenital anomalies 1, 2
  • Offer chromosomal microarray analysis (CMA) for unexplained isolated IUGR (GRADE 1C recommendation) 2
  • When amniocentesis is performed, offer PCR testing for cytomegalovirus 2
  • Do not routinely screen for toxoplasmosis, rubella, or herpes without specific risk factors—this wastes resources and delays appropriate management 2

For Late-Onset IUGR (≥32 weeks):

  • Focus on placental insufficiency as the predominant etiology 1
  • Evaluate for maternal hypertensive disorders and vascular disease 2
  • Genetic testing is less commonly indicated unless structural anomalies are present 2

Surveillance Protocol

For EFW 3rd-9th percentile with normal umbilical artery Doppler:

  • Umbilical artery Doppler every 1-2 weeks initially 6
  • If stable, extend interval to every 2-4 weeks 6
  • Biophysical profile (BPP) remains the mainstay of fetal well-being evaluation, assessing fetal breathing, movements, tone, and amniotic fluid volume 1

For severe IUGR (EFW <3rd percentile):

  • Weekly umbilical artery Doppler evaluation 6
  • Weekly cardiotocography (CTG) 6
  • More intensive monitoring is required regardless of Doppler findings due to 2.5% stillbirth risk 5

For abnormal umbilical artery Doppler (absent/reversed end-diastolic velocity):

  • Doppler assessment 2-3 times per week for absent end-diastolic velocity 6
  • Add middle cerebral artery and venous Doppler (especially ductus venosus) to assess fetal well-being and assist with delivery timing 1
  • Consider hospital admission if fetal surveillance more than 3 times per week is necessary 6

Delivery Timing Considerations

  • The predominant theme for all FGR pregnancies is individualized timing of surveillance and delivery based on gestational age, Doppler abnormalities, fetal well-being, and presence of structural defects or chromosomal abnormalities 1
  • Preterm FGR carries 2- to 5-fold increased perinatal death rates compared to term FGR 5
  • Knowledge of specific gestational age thresholds (28,32, or 34 weeks) helps guide management as these represent varying etiologies and pathologies 1

Long-Term Implications

  • IUGR is linked with lifelong health consequences including impaired intellectual performance in childhood and adult diseases such as hypertension, obesity, and cardiovascular disease 5
  • Acute neonatal consequences include perinatal asphyxia, respiratory distress from meconium aspiration, persistent pulmonary hypertension, abnormalities of glucose regulation, temperature instability, and polycythemia 3
  • IUGR preterm infants face increased incidence of chronic lung disease, necrotizing enterocolitis, retinopathy of prematurity, and postnatal growth failure 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asymmetric Intrauterine Growth Restriction Causes and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The IUGR newborn.

Seminars in perinatology, 2008

Research

Utility of head/abdomen circumference ratio in the evaluation of severe early-onset intrauterine growth restriction.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2011

Guideline

Fetal Growth Restriction Diagnosis and Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cut-off for Diagnosing IUGR in Anomaly Scan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is symmetric Intrauterine Growth Restriction (IUGR) and what causes it?
Which fetal abnormalities can cause intra‑uterine growth restriction (IUGR) and what are the recommended diagnostic and management approaches?
What is the most appropriate next step in management for a pregnant woman at 20 weeks gestation with a history of intrauterine growth restriction (IUGR) in a previous pregnancy?
What causes asymmetric Intrauterine Growth Restriction (IUGR) in a pregnant individual?
What is a reasonable screening tool for a fetus with intrauterine growth restriction (IUGR)?
What is the recommended first‑line treatment, dosing schedule, vaccination requirements, and monitoring for an adult with atypical hemolytic‑uremic syndrome, and what alternatives are available if eculizumab (Soliris) is contraindicated or ineffective?
Is hypertonic saline (3% NaCl) indicated for fluid resuscitation in a patient with active gastrointestinal bleeding?
What is the likely diagnosis and appropriate management for a 25‑year‑old man presenting with recurrent painless gross hematuria after an upper‑respiratory infection and mild proteinuria?
What is the appropriate evaluation and management for a reproductive‑age woman presenting with lower pelvic pain?
What is the pathophysiology of acute respiratory distress syndrome (ARDS) in neonates?
What is the recommended comprehensive management approach for lymphedema, including diagnosis, complete decongestive therapy, compression, adjunctive modalities, and surgical options?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.